We proposed a new HIV-1 therapeutic vaccine based on conserved cytotoxic T lymphocyte (CTL) epitopes of archived HIV-1 DNA according to their affinity to the dominant HLA-A and -B alleles of the population investigated. Our proposal (Hla Fitted VAC. HFVAC) was composed of 15 peptides originating from the RT. gag and nef parts of proviral DNA. https://www.markymarkscott.com/product-category/color-shampoo/